
GP @ConsciousFundHQ CEO & Co Founder @LongrHQ Chair @MicroDoseHQ Advisor @Hive__Bio @HealingREIT @Psychedelic_Med. #PsyMed 🍄 #Longevity 🧪 #AI 🤖
Malta
Joined October 2008
- Tweets12K
- Following1.8K
- Followers2.3K
- Likes4K
Richard Skaife 🍄 retweeted
Peptides are a revolutionary new healthcare platform
Incumbents are intelligent enough to understand it, but they have the short term incentives to pretend it doesn’t exist
It’s deflationary to a system that manages symptoms instead of healing at the root, which is what peptides do
Further, most of the value will not accrue to the peptides themselves, but to the data layer that is able to personalize peptides for anyone at a marginal cost to maximize healthcare outcomes
The above is the basis for longevity as a service, which will be far more valuable than any subscription service we’ve see to date. It’ll make Amazon look irrelevant and consumers will do everything in their power to continuously buy into longevity upgrades for themselves and their loved ones
Find out what’s happening in the fast moving peptide world. peptide.show
RT @Peptides__: The internet has a peptide recommendation for everyone. Your DNA doesn't.
Peptide analytics turns genetic signals into…
BREAKING: President Trump announces historic reforms to accelerate access to new medical research and treatments based on psychedelic drugs.
Trump will sign an executive order directing the FDA to expedite their review of certain psychedelics already designated as breakthrough therapy drugs.
Richard Skaife 🍄 retweeted
The PMA recently turned FIVE years old! With all our activity putting together research bulletins & our monthly webinars for our members, the anniversary date in September already came and went. However, even if it is late we wanted to make sure to share this exciting milestone!
Richard Skaife 🍄 retweeted
We cloned Gmail, except you're logged in as Epstein and can see his emails
Richard Skaife 🍄 retweeted
Cybin is pleased to announce a ~$175 million registered direct offering with prominent biotech investors.
Learn more: ir.cybin.com/investors/news/…
Richard Skaife 🍄 retweeted
We've completed the acquisition of Gilgamesh Pharmaceuticals' lead investigational asset. This expands our #psychiatry pipeline and underscores our commitment to pursue innovative approaches for #MentalHealth disorders. More: abbv.ie/4ce3d8
Richard Skaife 🍄 retweeted
1/ It feels surreal to announce completion of the first human trial in the development of our neurotech platform for designing mental states, from the molecular level.
Human experience is now programmable.
A🧵on the sequel to psychedelics & the first new "emotion in a bottle."
Richard Skaife 🍄 retweeted
JUST IN: We’ve signed a definitive agreement to acquire @GilgameshRX lead investigational therapy. This agreement demonstrates our commitment to pursuing novel treatment approaches and transforming patient care in #psychiatry. Learn more: abbv.ie/adg
Richard Skaife 🍄 retweeted
I founded @atai_life with one clear vision: to bring psychedelics back into mainstream medicine and establish ourselves as the leader in this transformative field.
Today, $ATAI has taken a significant step toward realizing that vision by cementing its leadership position through an all-stock merger with @BeckleyPsytech.
I am immensely grateful to Cosmo and to his late mother, the legendary Amanda Feilding, for choosing us as their partner. Without Amanda, the psychedelic renaissance would not exist. It is an incredible honor for Cosmo, @SriniGRao, me, and our teams to carry her legacy forward.
This merger creates a true psychedelic powerhouse:
1) All major, medically viable psychedelics under one roof
2) Focus on short in-clinic-time psychedelics, fitting the 2-hour treatment window established by J&J’s Spravato
3) Four major readouts expected within the next 12 months
4) A strong development pipeline of non-hallucinogenic neuroplasticity enhancers (you haven’t heard much about this yet—but you will soon. I’m super excited about this hidden gem)
5) Pharma is entering the space: Ferring Ventures SA, part of @ferring, has disclosed an existing stake in $ATAI and is doubling down
6) Committed anchor shareholders: Beckley shareholders receiving ATAI shares are locked up. I’ve also signed a voluntary lock-up for all of my shares on the same terms.
The future is psychedelic!
ir.atai.com/news-releases/ne…
Richard Skaife 🍄 retweeted
Almost all the patients with depression who received Gilgamesh Pharmaceuticals’ psychedelic drug candidate went into remission. fiercebiotech.com/biotech/gi…
Richard Skaife 🍄 retweeted
Today we announced positive topline data from our Phase 2a study of GM-2505 for Major Depressive Disorder.
Read more: prnewswire.com/news-releases…
Richard Skaife 🍄 retweeted
Congratulations to @OraBiomedical on fully funding subproject one - the first phase in a project that seeks out next-gen therapies more effective than rapamycin.
Learn more and contribute:
lifespan.io/news/the-mtor-in…
@KristerKauppi @mitchellblee33 @KeithComito @LifespanRI
Richard Skaife 🍄 retweeted
the optimal startup team in 2025 is 5 people.
1 engineer. 1 designer. 1 product lead. 1 growth lead. 1 ops person
that's it.
the engineer starts the day in Cursor. they paste in a product idea, and Cursor instantly generates the scaffolding. they edit inline with AI, refactor entire files with a single prompt, and navigate the repo by chatting with it. debugging feels like pair programming. documentation is auto-generated. by EOD, the idea is live. no waiting, team is stoked.
the designer doesn’t stop at Figma. they write the copy, shape the brand, talk to users, and launch prototypes in V0/Replit. sometimes they skip the handoff entirely. vibe coding is real, and it’s fast.
the product lead jumps between defining success metrics, community building, replying to support tickets, and building the strategy/tactics to build a big company. they are the glue.
growth lead is a mix of creative and technical. they are vibe marketing by hiring agents, setting up analytics, rewriting landing pages, testing distribution ideas, finding creators to work with and coming up with outlandish ideas to get people on social to stop scrolling on social and "look at me".
ops runs the quiet layer under everything. contracts, support, tools, hiring, money. no chaos. just speed.
you don’t feel the size of the team. you feel the surface area.
ai is everywhere, it's the co-founder to everyone on the team but in the background. it writes, supports, designs, scouts, and summarizes. no meetings about what to do. just people doing it.
instagram sold for $1B with 13 people.
the next $1B company will get there with 5.
this is how it plays out now.
not theoretical. not future.
already happening.
Richard Skaife 🍄 retweeted
The vaccine against Shingles helps protect against dementia, results of a natural experiment, adding to prior evidence
"implications are profound"
New @Nature
nature.com/articles/s41586-0…
nature.com/articles/d41586-0…
Richard Skaife 🍄 retweeted
Longevity at your fingertips. The blēo ring is now available. Sleek and powerful. bleo.ai
Richard Skaife 🍄 retweeted
Longr (@LongrHQ) launches the Longevity AI APP, a new, free app available for iOS and Android that leverages machine learning and biometric AI to deliver individualized health insights.
longevity.technology/news/lo…
Richard Skaife 🍄 retweeted
Longr launches The Longevity AI app
New AI-driven platform aims to offer biometric analysis, personalized longevity guidance and seamless wearable integration.
#diagnostics
longevity.technology/news/lo…
Richard Skaife 🍄 retweeted
On the Health Tech Stage, Richard Skaife, CEO & Founder of @LongrHQ and Javaid Sheikh, Dean of Cornell University Qatar, tackled one of the biggest challenges in healthcare.
Their discussion explored how personalised preventive healthcare, once a luxury for the few, can be made accessible to billions. With advancements in AI, biotech, and precision medicine, the future of longevity isn’t just about living longer but living healthier, at scale.
#LEAP25 #IntoNewWorlds

























